Sign In

7.6 : Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.

Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine is more resistant to hydrolysis by cholinesterases, they produce a prolonged depolarization that causes neuromuscular blockade and muscle paralysis. Adding cholinesterase inhibitors further enhances their effects instead of terminating their response, as seen with nondepolarizing blockers.

The effect of depolarizing blockers usually lasts 5-10 minutes. They are often used during an emergency for airway management, endotracheal intubation, or electroconvulsive shock therapy. However, succinylcholine should be avoided for patients with mutated cholinesterases or cholinesterase deficiency, as it can produce more prolonged neuromuscular blockade than desired.

Tags
Depolarizing BlockersMechanism Of ActionSkeletal Muscle FibersNeuromuscular BlockadeSuccinylcholineNicotinic Acetylcholine ReceptorsHydrolysis ResistanceCholinesterase InhibitorsMuscle ParalysisAirway ManagementEndotracheal IntubationElectroconvulsive Shock Therapy

From Chapter 7:

article

Now Playing

7.6 : Depolarizing Blockers: Mechanism of Action

Skeletal Muscle Relaxants

839 Views

article

7.1 : Neuromuscular Junction And Blockade

Skeletal Muscle Relaxants

1.9K Views

article

7.2 : Classification of Skeletal Muscle Relaxants

Skeletal Muscle Relaxants

2.1K Views

article

7.3 : Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Skeletal Muscle Relaxants

972 Views

article

7.4 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Skeletal Muscle Relaxants

276 Views

article

7.5 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Skeletal Muscle Relaxants

356 Views

article

7.7 : Depolarizing Blockers: Pharmocokinetics

Skeletal Muscle Relaxants

228 Views

article

7.8 : Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Skeletal Muscle Relaxants

433 Views

article

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

251 Views

article

7.10 : Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants

380 Views

article

7.11 : Spasmolytic Agents: Chemical Classification

Skeletal Muscle Relaxants

765 Views

article

7.12 : Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal Muscle Relaxants

2.6K Views

article

7.13 : Centrally Acting Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants

395 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved